DongKook Pharmaceutical (086450.KQ) Earnings Analysis

DongKook Pharmaceutical (086450.KQ) has no confirmed upcoming earnings date. Trailing P/E 11.15.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 086450.KQ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 086450.KQ. This page updates as the calendar is published.

086450.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15553.06 KRWn/an/an/a
2026-03-05308.92 KRWn/an/an/a
2025-05-15368.5 KRWn/an/an/a
2025-03-13195.93 KRWn/an/an/a
2024-11-14431 KRWn/an/an/a
2024-08-14304.21 KRWn/an/an/a

086450.KQ valuation and analyst view

Trailing P/E11.15
Trailing EPS1,651.87 KRW
Price / book1.23
Dividend yield1.08%
Market cap821.01B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is DongKook Pharmaceutical (086450.KQ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 086450.KQ. This page updates as the calendar is published.

Did 086450.KQ beat earnings last quarter?

Consensus estimate data was not available for 086450.KQ's 2026-05-15 report.

What is 086450.KQ's current P/E ratio and EPS?

086450.KQ trades at a trailing P/E of 11.15 on trailing EPS of 1651.871007071446 KRW.

What do analysts rate 086450.KQ?

086450.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.